Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161603 · ClinicalTrials.gov registry record
Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study
A clinical trial of Angioplasty Patients, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT00161603: Completed study of Angioplasty Patients, sponsored by Weill Medical College of Cornell University.
NCT00161603 is a study of Angioplasty Patients that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00161603, a study of Angioplasty Patients, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
To explore and illuminate the cultural, social, and psychological factors that either facilitate or serve as barriers to behavioral change in angioplasty patients. Through a series of open-ended questions we will explore and build a better understanding of how culturally different patient groups perceive heart disease and the difficulties in changing health behavior. In addition, we hope to better understand and anticipate barriers and issues that participants face in successfully changing their behaviors.
Conditions Studied
Interventions
- BEHAVIORAL Semi-structured, open-ended interviews
Study Locations (1)
New York
- The New York Presbyterian Hospital-Weill Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2003-04 |
| Est. Completion | 2003-09 |
What the finished NCT00161603 record still lists
NCT00161603 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 1 condition, with Angioplasty Patients appearing as the primary indexed condition, and to 1 intervention - of which Semi-structured, open-ended interviews is the first listed.
NCT00161603 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00161603 about?
NCT00161603 is a clinical study titled "Cornell Translational Behavioral Science Research Consortium: Angioplasty Qualitative Study". To explore and illuminate the cultural, social, and psychological factors that either facilitate or serve as barriers to behavioral change in angioplasty patients. Through a series of open-ended questions we will explore and build a better understanding of how culturally different patient groups per...
What is the current status of trial NCT00161603?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2003-04. Estimated completion is 2003-09.
What conditions does trial NCT00161603 study?
This clinical trial studies the following conditions: Angioplasty Patients.
What interventions are being tested in trial NCT00161603?
The interventions under investigation include: Semi-structured, open-ended interviews (BEHAVIORAL).
Who is sponsoring clinical trial NCT00161603?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00161603 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia